Matches in DBpedia 2014 for { <http://dbpedia.org/resource/BioCryst_Pharmaceuticals> ?p ?o. }
Showing items 1 to 72 of
72
with 100 items per page.
- BioCryst_Pharmaceuticals abstract "BioCryst Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina. The company focuses on orphan & autoimmune diseases, and antivirals. The company's most advanced drug candidate is the antiviral Peramivir, which is approved in Japan, Korea and China. It was authorized by the FDA for emergency use in the treatment of patients hospitalized with influenza during the 2009-10 influenza A virus subtype H1N1 pandemic.".
- BioCryst_Pharmaceuticals assets "57.4".
- BioCryst_Pharmaceuticals equity "-0.4".
- BioCryst_Pharmaceuticals foundingYear "1986".
- BioCryst_Pharmaceuticals industry Health_care.
- BioCryst_Pharmaceuticals keyPerson Chief_executive_officer.
- BioCryst_Pharmaceuticals keyPerson Chief_financial_officer.
- BioCryst_Pharmaceuticals location Durham,_North_Carolina.
- BioCryst_Pharmaceuticals netIncome "-39.1".
- BioCryst_Pharmaceuticals numberOfEmployees "37".
- BioCryst_Pharmaceuticals operatingIncome "-33.9".
- BioCryst_Pharmaceuticals product Biotechnology.
- BioCryst_Pharmaceuticals revenue "26.3".
- BioCryst_Pharmaceuticals type Public_company.
- BioCryst_Pharmaceuticals wikiPageExternalLink forum.
- BioCryst_Pharmaceuticals wikiPageExternalLink www.biocryst.com.
- BioCryst_Pharmaceuticals wikiPageID "22617127".
- BioCryst_Pharmaceuticals wikiPageRevisionID "574639075".
- BioCryst_Pharmaceuticals assets "US$57.4M".
- BioCryst_Pharmaceuticals equity "US$-0.4M".
- BioCryst_Pharmaceuticals foundation "1986".
- BioCryst_Pharmaceuticals hasPhotoCollection BioCryst_Pharmaceuticals.
- BioCryst_Pharmaceuticals homepage www.biocryst.com.
- BioCryst_Pharmaceuticals industry Health_care.
- BioCryst_Pharmaceuticals keyPeople "Jon P. Stonehouse , President and Chief Executive Officer".
- BioCryst_Pharmaceuticals keyPeople "Thomas Staab II, Chief Financial Officer".
- BioCryst_Pharmaceuticals location "Durham, North Carolina, USA".
- BioCryst_Pharmaceuticals logo File:BioCryst_Logo.gif.
- BioCryst_Pharmaceuticals name "BioCryst Pharmaceuticals, Inc.".
- BioCryst_Pharmaceuticals netIncome "US$-39.1M".
- BioCryst_Pharmaceuticals numEmployees "37".
- BioCryst_Pharmaceuticals operatingIncome "US$-33.9M".
- BioCryst_Pharmaceuticals products Biotechnology.
- BioCryst_Pharmaceuticals revenue "US$26.3M".
- BioCryst_Pharmaceuticals type Public_company.
- BioCryst_Pharmaceuticals subject Category:Companies_based_in_Birmingham,_Alabama.
- BioCryst_Pharmaceuticals subject Category:Companies_in_the_NASDAQ_Biotechnology_Index.
- BioCryst_Pharmaceuticals subject Category:Companies_listed_on_NASDAQ.
- BioCryst_Pharmaceuticals subject Category:Pharmaceutical_companies_of_the_United_States.
- BioCryst_Pharmaceuticals type Abstraction100002137.
- BioCryst_Pharmaceuticals type CompaniesBasedInBirmingham,Alabama.
- BioCryst_Pharmaceuticals type CompaniesInTheNASDAQBiotechnologyIndex.
- BioCryst_Pharmaceuticals type CompaniesListedOnNASDAQ.
- BioCryst_Pharmaceuticals type Company108058098.
- BioCryst_Pharmaceuticals type DrugCompany108002578.
- BioCryst_Pharmaceuticals type Group100031264.
- BioCryst_Pharmaceuticals type Institution108053576.
- BioCryst_Pharmaceuticals type Organization108008335.
- BioCryst_Pharmaceuticals type PharmaceuticalCompaniesOfTheUnitedStates.
- BioCryst_Pharmaceuticals type SocialGroup107950920.
- BioCryst_Pharmaceuticals type YagoLegalActor.
- BioCryst_Pharmaceuticals type YagoLegalActorGeo.
- BioCryst_Pharmaceuticals type YagoPermanentlyLocatedEntity.
- BioCryst_Pharmaceuticals type Agent.
- BioCryst_Pharmaceuticals type Company.
- BioCryst_Pharmaceuticals type Organisation.
- BioCryst_Pharmaceuticals type Organization.
- BioCryst_Pharmaceuticals type Agent.
- BioCryst_Pharmaceuticals type SocialPerson.
- BioCryst_Pharmaceuticals type Thing.
- BioCryst_Pharmaceuticals comment "BioCryst Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina. The company focuses on orphan & autoimmune diseases, and antivirals. The company's most advanced drug candidate is the antiviral Peramivir, which is approved in Japan, Korea and China. It was authorized by the FDA for emergency use in the treatment of patients hospitalized with influenza during the 2009-10 influenza A virus subtype H1N1 pandemic.".
- BioCryst_Pharmaceuticals label "BioCryst Pharmaceuticals".
- BioCryst_Pharmaceuticals label "バイオクリスト".
- BioCryst_Pharmaceuticals sameAs バイオクリスト.
- BioCryst_Pharmaceuticals sameAs m.02h67nr.
- BioCryst_Pharmaceuticals sameAs Q4914611.
- BioCryst_Pharmaceuticals sameAs Q4914611.
- BioCryst_Pharmaceuticals sameAs BioCryst_Pharmaceuticals.
- BioCryst_Pharmaceuticals wasDerivedFrom BioCryst_Pharmaceuticals?oldid=574639075.
- BioCryst_Pharmaceuticals homepage www.biocryst.com.
- BioCryst_Pharmaceuticals isPrimaryTopicOf BioCryst_Pharmaceuticals.
- BioCryst_Pharmaceuticals name "BioCryst Pharmaceuticals, Inc.".